Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124241) titled 'An Evaluation of the Efficacy and Safety Profiles of 0.4% versus 1% Lidocaine Stellate Ganglion Block in Patients with Sleep Disorders' on May 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Sleep disorder
Intervention:
Trial Group:0.4% Lidocaine, 4mL, ultrasound-guided stellate ganglion block (SGB) treatment, total 7 times
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-11
Target Sample Size: Trial Group:73;Control Group:73;
Countries of Recruitment:
China
To know more, visit https://www.c...